共 50 条
- [36] Clinical effects of STW 5 (Iberogast®) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (06): : 632 - e25
- [37] KC 11458 - A novel motilin agonist for the treatment of functional dyspepsia with delayed gastric emptying or diabetic gastroparesis? [J]. Functional Disorders of the Gastrointestinal Tract, 2005, 3 : 89 - 102
- [40] Comparison of Gastric Volumes and Emptying in Functional Dyspepsia [J]. GASTROENTEROLOGY, 2009, 136 (05) : A784 - A784